Abivax S.A. Adjustments For Income Tax Expense
Abivax S.A. (ABVX) reported Adjustments For Income Tax Expense of EUR 5.85 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2026-03-23
| Period end | Adjustments For Income Tax Expense 12 month |
|---|---|
| 2025-12-31 | 5.85M EUR 20-F · filed 2026-03-23 |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-03-23 |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-03-23 |